Tag: Cognition and Cognitive Therapy

Small improvement seen in global cognition scores, but no different from those following control diet with mild caloric restriction

Mean change in Preclinical Alzheimer Cognitive Composite score not significantly different at 240 weeks with solanezumab, placebo

In active and retired fighters who were TES-positive, the rate of cognitive decline was significantly greater for reaction time

Significant main effect was only seen for absorption training, but not for other factors, including activity scheduling, relaxation

Beneficial effects seen for 12 weekly sessions of cognitive behavioral therapy and/or pharmacotherapy using stepped approach

Emotion perception and processing performance tied to age in those with psychotic disorders and controls, while theory of mind performance only linked to age in patients

Myocardial infarction not associated with decrease in global cognition, memory, executive function

However, no associations seen for blood pressure or cholesterol levels

Protective effect suggested with female gender for schizophrenia patients with tardive dyskinesia

In some cases, cognitive impairment is reversible, but up to one-third of individuals with stroke develop dementia within five years